Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arja Viinanen

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Duodecim; Laaketieteellinen Aikakauskirja|January 20, 2007
[Not Available]Eija-Riitta Salomaa, Arja Viinanen
Journal of Allergy|July 13, 2011
Gum arabic as a cause of occupational allergyArja Viinanen, Maija Salokannel, Kaija Lammintausta
Journal of Asthma and Allergy|July 25, 2024
Healthcare Resource Utilisation of Severe Uncontrolled T2low and Non-T2low Asthma in Finland During 2018-2021Josefine Persson, Juhani Aakko, Saara Kaijala, et al.
Biomolecules|July 29, 2023
Type 2 Low Biomarker Stability and Exacerbations in Severe Uncontrolled AsthmaArja Viinanen, Juhani Aakko, Mariann I Lassenius, et al.
International Journal of Chronic Obstructive Pulmonary Disease|November 22, 2019
The Burden Of Chronic Obstructive Pulmonary Disease (COPD) In Finland: Impact Of Disease Severity And Eosinophil Count On Healthcare Resource UtilizationArja Viinanen, Mariann I Lassenius, Iiro Toppila, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 11, 2025
Factors associated with the development of severe asthma: A nationwide study (FINASTHMA)Arja Viinanen, Pinja Ilmarinen, Juha Mehtälä, et al.
Journal of Asthma and Allergy|October 30, 2025
Impact of Asthma Severity and Exacerbation Frequency on Burden of Disease Related Costs in FinlandMariann I Lassenius, Juhani Aakko, Sara Hallberg, et al.
The Journal of Allergy and Clinical Immunology. in Practice|October 5, 2023
Comorbidity Burden in Severe and Nonsevere Asthma: A Nationwide Observational Study (FINASTHMA)Hannu Kankaanranta, Arja Viinanen, Pinja Ilmarinen, et al.
The Journal of Allergy and Clinical Immunology. Global|April 25, 2025
Burden of asthma by severity and exacerbation frequency among adult patients naive to biologic asthma therapy: A Finnish cohort studyHannu Kankaanranta, Arja Viinanen, Anton Klåvus, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|January 31, 2022
Effectiveness of mepolizumab in patients with severe eosinophilic asthma: results from real-world clinical practice in FinlandVille Koistinen, Paula Kauppi, Juhana Idänpään-Heikkilä, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Duodecim; Laaketieteellinen Aikakauskirja|January 20, 2007
[Not Available]Eija-Riitta Salomaa, Arja Viinanen
Journal of Allergy|July 13, 2011
Gum arabic as a cause of occupational allergyArja Viinanen, Maija Salokannel, Kaija Lammintausta
Journal of Asthma and Allergy|July 25, 2024
Healthcare Resource Utilisation of Severe Uncontrolled T2low and Non-T2low Asthma in Finland During 2018-2021Josefine Persson, Juhani Aakko, Saara Kaijala, et al.
Biomolecules|July 29, 2023
Type 2 Low Biomarker Stability and Exacerbations in Severe Uncontrolled AsthmaArja Viinanen, Juhani Aakko, Mariann I Lassenius, et al.
International Journal of Chronic Obstructive Pulmonary Disease|November 22, 2019
The Burden Of Chronic Obstructive Pulmonary Disease (COPD) In Finland: Impact Of Disease Severity And Eosinophil Count On Healthcare Resource UtilizationArja Viinanen, Mariann I Lassenius, Iiro Toppila, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 11, 2025
Factors associated with the development of severe asthma: A nationwide study (FINASTHMA)Arja Viinanen, Pinja Ilmarinen, Juha Mehtälä, et al.
Journal of Asthma and Allergy|October 30, 2025
Impact of Asthma Severity and Exacerbation Frequency on Burden of Disease Related Costs in FinlandMariann I Lassenius, Juhani Aakko, Sara Hallberg, et al.
The Journal of Allergy and Clinical Immunology. in Practice|October 5, 2023
Comorbidity Burden in Severe and Nonsevere Asthma: A Nationwide Observational Study (FINASTHMA)Hannu Kankaanranta, Arja Viinanen, Pinja Ilmarinen, et al.
The Journal of Allergy and Clinical Immunology. Global|April 25, 2025
Burden of asthma by severity and exacerbation frequency among adult patients naive to biologic asthma therapy: A Finnish cohort studyHannu Kankaanranta, Arja Viinanen, Anton Klåvus, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|January 31, 2022
Effectiveness of mepolizumab in patients with severe eosinophilic asthma: results from real-world clinical practice in FinlandVille Koistinen, Paula Kauppi, Juhana Idänpään-Heikkilä, et al.
Pageof 2